Skip Navigation


Japanese Journal of Clinical Oncology Advance Access originally published online on January 17, 2006
Japanese Journal of Clinical Oncology 2006 36(2):116-120; doi:10.1093/jjco/hyi225
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
36/2/116    most recent
hyi225v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Ito, M.
Right arrow Articles by Ogawa, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ito, M.
Right arrow Articles by Ogawa, O.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© 2006 Foundation for Promotion of Cancer Research

Cancer Genetics Report

Association of the PIG3 Promoter Polymorphism with Invasive Bladder Cancer in a Japanese Population

Masaaki Ito1, Hiroyuki Nishiyama1, Jun Watanabe1, Hiroaki Kawanishi1, Takeshi Takahashi1, Toshiyuki Kamoto1, Tomonori Habuchi2 and Osamu Ogawa1

1 Department of Urology, Kyoto University Graduate School of Medicine, Kyoto and 2 Department of Urology, Akita University of Medicine, Akita, Japan

For reprints and all correspondence: Osamu Ogawa, Department of Urology, Kyoto University, Graduate School of Medicine, 54 Shogoin Kawaharacho, Sakyo-ku 606-8507, Kyoto, Japan. E-mail: ogawao{at}kuhp.kyoto-u.ac.jp

Received September 13, 2005; accepted November 30, 2005

PIG3 (p53-induced gene 3) is one of the targets of TP53 and is involved in apoptosis. The promoter of PIG3 contains a variable number of tandem repeats (VNTRs) of pentanucleotides (TGYCC)n (Y = C or T) and the number of VNTRs was reported to be correlated with the activation by TP53. In this study, the clinical significance of the PIG3 promoter VNTRs was analyzed in the bladder cancer patients using the genome DNAs from 338 controls and 273 bladder cancer patients. There was no significant difference in the allele frequency of the PIG3 promoter VNTRs between them. However, the presence of 14 or less repeats allele was associated with higher cancer grade (P = 0.038) and higher stage in relative risk (adjusted odds ratio = 2.31, 95% confidence interval = 1.05–5.90). These data suggested that the PIG3 promoter VNTRs was associated with generation of invasive bladder cancer.

Key Words: PIG3 • bladder cancer • VNTRs


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
S. Porte, E. Valencia, E. A. Yakovtseva, E. Borras, N. Shafqat, J. E. Debreczeny, A. C. W. Pike, U. Oppermann, J. Farres, I. Fita, et al.
Three-dimensional Structure and Enzymatic Function of Proapoptotic Human p53-inducible Quinone Oxidoreductase PIG3
J. Biol. Chem., June 19, 2009; 284(25): 17194 - 17205.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.